[Angiotensin II receptor antagonists. Clinical relevance].
Scholze
J
J
Medizinische Poliklinik/Ambulante Spezialmedizin, Berlin.
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005352:Fibromuscular Dysplasia / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy* / Q000503:physiopathology; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use; D019808:Losartan; D016032:Randomized Controlled Trials as Topic; D011945:Receptors, Angiotensin / Q000502:physiology; D013329:Structure-Activity Relationship; D013777:Tetrazoles / Q000009:adverse effects / Q000627:therapeutic use; D014882:Water-Electrolyte Balance / Q000187:drug effects / Q000502:physiology
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D007093:Imidazoles; D011945:Receptors, Angiotensin; D013777:Tetrazoles; D019808:Losartan
Angiotensin-II-Rezeptor-Antagonisten. Klinische Relevanz.